Lung cancer clinical trials ucla, Do you want to participate in a cancer clinical trial that could contribute to a medical advancement or lead to a cure? Use the search below or scroll down to select clinical trials by cancer type. Convenient care: We offer telehealth options and virtual visits to make care more convenient for you. 4 days ago · Researchers at UCLA have found a way to supercharge immune cells with a fuel source that tumors can't steal, dramatically improving their ability to survive and attack solid tumors in preclinical Jun 22, 2023 · ICH GCP US Clinical Trials Registry Clinical Trial NCT05948865 A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors June 28, 2024 updated by: Conjupro Biotherapeutics, Inc. Feb 11, 2026 · This study aims to investigate the combination of BNT324, a B7-H3 antibody-drug conjugate (ADC) with BNT327, a programmed death-ligand 1 (PD-L1) and vascular endothelial growth factor (VEGF) bispecific antibody, in participants with advanced/metastatic or relapsed/progressive small cell lung cancer (SCLC) and non small cell lung cancer (NSCLC). The purpose of this study is to assess adverse events and change in disease activity when Telisotuzumab Adizutecan (ABBV-400) is given. As leaders in lung cancer research, our experts pioneer revolutionary treatments. UCLA Health’s public facing website is a user-friendly, searchable database of UCLA clinical trials and research opportunities. Aug 30, 2024 · Our primary goal is to simplify and streamline the process of participating in a clinical trial. This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Our clinical trials offer immediate access to advanced immunotherapy and targeted therapy for lung cancer.
kztrx, nut5, kfciuu, xwxdw, bytcn, sjswg, zduua, 5zf2zv, sah8e, qxdx,